Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The current conceptualization of negative symptoms in schizophrenia
Stephen R. Marder, Silvana Galderisi
World Psychiatry (2017) Vol. 16, Iss. 1, pp. 14-24
Open Access | Times Cited: 441

Showing 26-50 of 441 citing articles:

A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale
Armida Mucci, Annarita Vignapiano, István Bitter, et al.
European Neuropsychopharmacology (2019) Vol. 29, Iss. 8, pp. 947-959
Open Access | Times Cited: 72
Reconsidering the Latent Structure of Negative Symptoms in Schizophrenia: A Review of Evidence Supporting the 5 Consensus Domains
Gregory P. Strauss, Anthony O. Ahmed, Jared W. Young, et al.
Schizophrenia Bulletin (2018) Vol. 45, Iss. 4, pp. 725-729
Open Access | Times Cited: 69
Motor dysfunction as research domain in the period preceding manifest schizophrenia: A systematic review
Dušan Hirjak, Andreas Meyer‐Lindenberg, Katharina M. Kubera, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 87, pp. 87-105
Closed Access | Times Cited: 64
Intrinsic Connectivity Patterns of Task-Defined Brain Networks Allow Individual Prediction of Cognitive Symptom Dimension of Schizophrenia and Are Linked to Molecular Architecture
Ji Chen, Veronika I. Müller, Juergen Dukart, et al.
Biological Psychiatry (2020) Vol. 89, Iss. 3, pp. 308-319
Open Access | Times Cited: 58
Acoustic speech markers for schizophrenia-spectrum disorders: a diagnostic and symptom-recognition tool
Janna N. de Boer, Alban Voppel, Sanne Brederoo, et al.
Psychological Medicine (2021) Vol. 53, Iss. 4, pp. 1302-1312
Open Access | Times Cited: 53
Digital phenotyping of negative symptoms: the relationship to clinician ratings
Alex S. Cohen, Elana Schwartz, Thanh P. Le, et al.
Schizophrenia Bulletin (2020) Vol. 47, Iss. 1, pp. 44-53
Open Access | Times Cited: 52
Disease-Related Risk Factors for Caregiver Burden among Family Caregivers of Persons with Schizophrenia: A Systematic Review and Meta-Analysis
Man‐Man Peng, Jianli Xing, Xinfeng Tang, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 3, pp. 1862-1862
Open Access | Times Cited: 36
Rates and Predictors of Disengagement and Strength of Engagement for People With a First Episode of Psychosis Using Early Intervention Services: A Systematic Review of Predictors and Meta-analysis of Disengagement Rates
Elizabeth Robson, Kathryn Greenwood
Schizophrenia Bulletin Open (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 33
Current Findings and Potential Mechanisms of KarXT (Xanomeline–Trospium) in Schizophrenia Treatment
Ali Azargoonjahromi
Clinical Drug Investigation (2024) Vol. 44, Iss. 7, pp. 471-493
Closed Access | Times Cited: 7
Efficacy of cariprazine on negative symptoms in patients with acute schizophrenia: A post hoc analysis of pooled data
Willie Earley, Hua Guo, David G. Daniel, et al.
Schizophrenia Research (2018) Vol. 204, pp. 282-288
Open Access | Times Cited: 59
Cognitive remediation can improve negative symptoms and social functioning in first-episode schizophrenia: A randomized controlled trial
Joseph Ventura, Kenneth L. Subotnik, Denise Gretchen‐Doorly, et al.
Schizophrenia Research (2017) Vol. 203, pp. 24-31
Open Access | Times Cited: 58
Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: results of supervised machine learning
Buranee Kanchanatawan, Sira Sriswasdi, Supaksorn Thika, et al.
Metabolic Brain Disease (2018) Vol. 33, Iss. 4, pp. 1053-1067
Closed Access | Times Cited: 52
Validation of the Brief Negative Symptom Scale and its association with functioning
Mei San Ang, Gurpreet Rekhi, Jimmy Lee
Schizophrenia Research (2019) Vol. 208, pp. 97-104
Open Access | Times Cited: 50
Understanding the Association Between Negative Symptoms and Performance on Effort-Based Decision-Making Tasks: The Importance of Defeatist Performance Beliefs
L. Felice Reddy, William P. Horan, Deanna M. Barch, et al.
Schizophrenia Bulletin (2017) Vol. 44, Iss. 6, pp. 1217-1226
Open Access | Times Cited: 49
Heterogeneity and Polygenicity in Psychiatric Disorders: A Genome-Wide Perspective
Frank R. Wendt, Gita A. Pathak, Daniel S. Tylee, et al.
Chronic Stress (2020) Vol. 4
Open Access | Times Cited: 49
Antipsychotic treatment – a systematic literature review and meta-analysis of qualitative studies
Jone Bjørnestad, Kristina Osland Lavik, Larry Davidson, et al.
Journal of Mental Health (2019) Vol. 29, Iss. 5, pp. 513-523
Open Access | Times Cited: 47
A transnosographic approach of negative symptoms pathophysiology in schizophrenia and depressive disorders
Sélim Benjamin Guessoum, Yann Le Strat, Caroline Dubertret, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 99, pp. 109862-109862
Open Access | Times Cited: 42
The Latent Structure of Negative Symptoms in Individuals With Attenuated Psychosis Syndrome and Early Psychosis: Support for the 5 Consensus Domains
Wing Chung Chang, Gregory P. Strauss, Anthony O. Ahmed, et al.
Schizophrenia Bulletin (2020) Vol. 47, Iss. 2, pp. 386-394
Open Access | Times Cited: 42
Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of Schizophrenia
Qiongqiong Wu, Xiaoyi Wang, Ying Wang, et al.
Neuroscience Bulletin (2021) Vol. 37, Iss. 11, pp. 1609-1624
Open Access | Times Cited: 41
The Effects of Anhedonia in Social Context
Emma Barkus
Current Behavioral Neuroscience Reports (2021) Vol. 8, Iss. 3, pp. 77-89
Open Access | Times Cited: 38
Updated perspectives on the clinical significance of negative symptoms in patients with schizophrenia
Giulia Maria Giordano, Edoardo Caporusso, Pasquale Pezzella, et al.
Expert Review of Neurotherapeutics (2022) Vol. 22, Iss. 7, pp. 541-555
Open Access | Times Cited: 28
Effects of bilateral, bipolar-nonbalanced, frontal transcranial Direct Current Stimulation (tDCS) on negative symptoms and neurocognition in a sample of patients living with schizophrenia: Results of a randomized double-blind sham-controlled trial
Jacopo Lisoni, Giulia Baldacci, Gabriele Nibbio, et al.
Journal of Psychiatric Research (2022) Vol. 155, pp. 430-442
Closed Access | Times Cited: 26
Theories and models of negative symptoms in schizophrenia and clinical implications
Raymond C. K. Chan, Lingling Wang, Simon S. Y. Lui
Nature Reviews Psychology (2022) Vol. 1, Iss. 8, pp. 454-467
Closed Access | Times Cited: 24
The relationship between negative symptoms and MATRICS neurocognitive domains: A meta-analysis and systematic review
Christy Au-Yeung, Danielle Penney, Jesse Rae, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 127, pp. 110833-110833
Closed Access | Times Cited: 14
The structure stability of negative symptoms: longitudinal network analysis of the Brief Negative Symptom Scale in people with schizophrenia
Paola Rucci, Edoardo Caporusso, Francesco Sanmarchi, et al.
BJPsych Open (2023) Vol. 9, Iss. 5
Open Access | Times Cited: 14

Scroll to top